Literature DB >> 16971649

In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.

Borann Sar1, Sambo Boy, Chantary Keo, Chan Chhaya Ngeth, Narom Prak, Mich Vann, Didier Monchy, Jean Louis Sarthou.   

Abstract

Penicillium marneffei infection is an important disease among human immunodeficiency virus patients in Southeast Asia. The in vitro antifungal-drug susceptibilities of 29 clinical isolates and 5 isolates from bamboo rats collected from 2002 to 2004 were determined. The P. marneffei yeast form is more susceptible than the mycelial form to amphotericin B and ketoconazole, while the mycelial and yeast forms displayed similar susceptibilities to flucytosine and itraconazole. The MICs of fluconazole were higher for both mycelial and yeast forms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971649      PMCID: PMC1698326          DOI: 10.1128/JCM.00902-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Penicillium marneffei: another pathogen to consider in patients infected with human immunodeficiency virus.

Authors:  D N Tsang; P C Li; M S Tsui; Y T Lau; K F Ma; E K Yeoh
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

2.  Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules.

Authors:  C H Koks; P L Meenhorst; M J Hillebrand; A Bult; J H Beijnen
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; S A Messer; A Bolmström; F C Odds; J H Rex
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

4.  In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.

Authors:  A S Sekhon; A K Garg; A A Padhye; Z Hamir
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

5.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 6.  Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.

Authors:  P Francis; T J Walsh
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

7.  Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages.

Authors:  N Kudeken; K Kawakami; A Saito
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

8.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

9.  Penicillium marneffei infection in patients infected with human immunodeficiency virus.

Authors:  K Supparatpinyo; S Chiewchanvit; P Hirunsri; C Uthammachai; K E Nelson; T Sirisanthana
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

10.  Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.

Authors:  T Koizumi; K Kubo; T Kaneki; M Hanaoka; T Hayano; T Miyahara; K Okada; K Fujimoto; H Yamamoto; T Kobayashi; M Sekiguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  3 in total

1.  Melanization and morphological effects on antifungal susceptibility of Penicillium marneffei.

Authors:  Jutikul Kaewmalakul; Joshua D Nosanchuk; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  Antonie Van Leeuwenhoek       Date:  2014-09-17       Impact factor: 2.271

2.  Penicillium marneffei Infection in AIDS.

Authors:  Stephenie Y N Wong; K F Wong
Journal:  Patholog Res Int       Date:  2011-02-10

3.  MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China).

Authors:  Lili Fang; Minxue Liu; Chunlan Huang; Jian Guo; Xiaobo Ma; Yanqing Zheng; Wenjuan Wu; Jiangshan Huang; Heping Xu
Journal:  Infect Drug Resist       Date:  2022-07-01       Impact factor: 4.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.